Pharmacogenetics progress of commonly-used chemotherapeutic drugs for acute leukemia / 白血病·淋巴瘤
Journal of Leukemia & Lymphoma
;
(12): 317-320, 2020.
Artículo
en Chino
| WPRIM
| ID: wpr-862832
ABSTRACT
Leukemia is a common and harmful disease for humans. Chemotherapy is the main treatment method. During the decades of experience, the clinicians have found that these drugs work well, but obvious individual differences occur in different patients. Some concerns of the clinicians exist such as how to learn more about the factors that may induce drug resistance and adverse reactions, and how to improve the efficacy of chemotherapy drugs, reduce drug resistance and side effects. This paper reviews the effect of genetic factors of commonly-used chemotherapeutic drugs for acute leukemia, aiming to provide a theoretical foundation for personalized administration of these chemotherapeutic drugs.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Journal of Leukemia & Lymphoma
Año:
2020
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS